• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Expansion

Optum Vetures et al. back $26m series-B for Kaia Health

  • Harriet Matthews
  • Harriet Matthews
  • 19 June 2020
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Optum Ventures, Idinvest and Capital300 have led a $26m funding round for Germany-based online rehabilitation and therapy provider Kaia Health.

Existing investors Balderton Capital, Heartcore Capital and Symphony Ventures also backed the round.

Kaia plans to use the fresh capital to launch new therapies, including its therapy programme for knee and hip osteoarthritis. It launched its chronic obstructive pulmonary disease (COPD) therapy in April 2020. The company also plans to hire more staff for its product development and technology teams.

Kaia Health

  • DEAL:

    Expansion

  • VALUE:

    $26m

  • LOCATION:

    Munich

  • SECTOR:

    Software

  • FOUNDED:

    2016

  • STAFF:

    67

New investor Idinvest is currently deploying equity from Idinvest Digital Fund III. The vehicle held a final close in October 2019 on €350m. The fund invests €3-10m per company, targeting series-A and series-B rounds.

Austria-based Capital300 generally invests in series-A rounds for Europe-based technology companies that intend to expand internationally, investing more than $1m per round along with other VC investors.

Previous funding
In June 2016, 42Cap and Otto Capital led a $4m seed round for Kaia.

Balderton led a $10m round for the company in January 2019, investing via Balderton VI, which held a final close in November 2017 on $375m. In September 2019, Optum led a $8m round for Kaia.

Company
Kaia designs and provides online therapies to treat and provide rehabilitation for chronic conditions including musculoskeletal pain and COPD. The AI-based platform monitors and analyses its users' movements to offer instructions, tracking 23 key points in the body. Kaia's app has 400,000 users.

The company was founded in 2016 and is based in Munich, with an additional office in New York. It has 67 employees, according to LinkedIn.

People
Kaia Health
– Konstantin Mehl (founder, CEO).
Optum Ventures – Heather Roxborough (partner).
Idinvest – Antoine Zins (venture capital investor); Matthieu Baret (managing partner).
Capital300 – Peter Lasinger, Roman Scharf (partners).
Balderton Capital – James Wise (partner).
Heartcore Capital – Christian Jepsen (partner).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Expansion
  • DACH
  • Technology
  • Venture
  • Germany
  • Balderton Capital
  • IDInvest Partners (AGF Private Equity)

More on Expansion

Wealth managers and financial advisers
Blackstone takes minority stake in Groupe Premium

Deal values French wealth manager at EUR 1.15bn after earlier full exit attempt saw Eurazeo target EUR 1.5bn

  • Expansion
  • 31 July 2023
Risk and compliance management services
e-Attestations aims to triple size with new Keensight backing

Keensight is investing in the risk management platform via its EUR 1bn fifth fund, which closed in 2019

  • Expansion
  • 25 July 2023
Bolt-ons and buy-and-build platforms
The Bolt-Ons Digest - 3 July 2023

Unquote’s selection of the latest add-ons with Palatine's Anthesis, Nordic Capital's Regnology, Waterland's Janssen and more

  • Expansion
  • 03 July 2023
Valentina Vitali of Limerston Capital
GP Profile: Limerston Capital anticipates higher volume but more complex M&A as market steadies

UK-based GP is seeing dealflow driven by carve-outs and buy-and-build in a market where organic multiple arbitrage is no longer a given

  • GPs
  • 07 June 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013